HomeKTTA • NASDAQ
add
Pasithea Therapeutics Corp
Previous close
$0.72
Day range
$0.69 - $0.74
Year range
$0.28 - $3.79
Market cap
17.46M USD
Avg Volume
458.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.09M | 86.89% |
Net income | -10.11M | -218.19% |
Net profit margin | — | — |
Earnings per share | -0.89 | — |
EBITDA | -5.93M | -91.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.16M | 696.78% |
Total assets | 60.24M | 274.98% |
Total liabilities | 5.02M | 291.63% |
Total equity | 55.22M | — |
Shares outstanding | 24.94M | — |
Price to book | 0.30 | — |
Return on assets | -41.23% | — |
Return on capital | -45.17% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -10.11M | -218.19% |
Cash from operations | -5.40M | -120.91% |
Cash from investing | 11.00K | — |
Cash from financing | 56.42M | 239,682.21% |
Net change in cash | 51.04M | 2,192.99% |
Free cash flow | 141.14K | 110.65% |
About
Founded
2020
Headquarters
Website
Employees
5
